ALLOS THERAPEUTICS, INC. (a Delaware corporation) 7,750,000 Shares of Common Stock PURCHASE AGREEMENTPurchase Agreement • April 2nd, 2009 • Allos Therapeutics Inc • Pharmaceutical preparations • New York
Allos Therapeutics, Inc., a Delaware corporation (the "Company"), confirms its agreement with UBS Securities LLC ("UBS") with respect to (i) the issue and sale by the Company and the purchase by UBS of 7,750,000 shares of the Company's common stock, par value $.001 per share (the "Common Stock") and (ii) the grant by the Company to UBS of the option described in Section 2(b) hereof to purchase all or any part of 1,162,500 additional shares of Common Stock to cover overallotments, if any. The aforesaid 7,750,000 shares of Common Stock (the "Initial Securities") to be purchased by UBS and all or any part of the 1,162,500 shares of Common Stock subject to the option described in Section 2(b) hereof (the "Option Securities") are hereinafter called, collectively, the "Securities."
